BF-168 also inhibited abnormal PrP formation in TSE-infected cells with IC50 = 0.4 nM in ScN2a cell line model and prolonged the lives (~11.4%) of mice infected intracerebrally with TSE when the compound was administered intravenously at the preclinical stage. This evidence concerns the gene PRNP and human prion disease.